23 March Abarceo attended RESI Premier Financing Event to meet investors and partners, interested in changing the diabetes therapeutics field.
Abarceo presented it’s aim to release the first oral treatment for Type 1 Diabetes and the first drug providing enhanced insulin sensitivity drug for Type 2 Diabetes.
Recent Comments